fluorodeoxyglucose f18 has been researched along with Psoriasis in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 25 (78.13) | 24.3611 |
| 2020's | 7 (21.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Kapoor, P; Keel, A; Manyak, G; Mehta, NN; Osborne, MT; Pantoja, C; Parel, P; Patel, NH; Playford, MP; Rodante, JA; Scott, C; Sorokin, AV; Svirydava, M; Tawakol, A; Teague, H; Teklu, M; Zhou, W | 1 |
| Dey, AK; Manyak, GA; Mehta, NN; Parel, PM; Patel, NH; Playford, MP; Sorokin, AV; Svirydava, M; Teague, HL; Teklu, M; Zhou, W | 1 |
| Alavi, A; Armstrong, AW; Blauvelt, A; Fitzsimmons, R; Gelfand, JM; Gottlieb, S; Kalb, RE; Lockshin, BN; Manyak, GA; Mehta, NN; Mendelsohn, L; Noe, MH; Papadopoulos, M; Parel, P; Playford, MP; Rodante, J; Shin, DB; Syed, MN; Tyring, SK; Wan, J; Werner, TJ | 1 |
| Beanlands, RS; Boczar, KE; deKemp, RA; Dwivedi, G; Fehlmann, CA; Glassman, SJ; Karsh, J; Wang, J; Ward, NC; Wells, GA; Zeng, W | 1 |
| Ahlman, MA; Blocki, F; Bonelli, F; Chen, MY; Dey, AK; Elnabawi, YA; Harrington, CL; Joshi, AA; Mehta, NN; Playford, MP; Rivers, JP; Rodante, JA; Teague, HL; Zierold, C | 1 |
| Ahlman, MA; Alavi, A; Armstrong, AW; Blauvelt, A; Dey, AK; Duffin, KC; Gelfand, JM; Gottlieb, S; Joshi, AA; Kianifard, F; Lockshin, BN; Mehta, NN; Menter, A; Muscianisi, E; Playford, MP; Sarkar, RP; Shin, DB; Simpson, EL; Steadman, J; Tyring, SK; Werner, TJ | 1 |
| Becker, C; Gørtz, PM; Hansen, PR; Henningsen, KMA; Kaiser, H; Krakauer, M; Kvist-Hansen, A; Skov, L; Wang, X | 1 |
| Hunter, HJA | 1 |
| Aberra, TM; Ahlman, MA; Baumer, Y; Chaturvedi, A; Chung, JH; Dey, AK; Ehrlich, A; Gelfand, JM; Gerson, E; Green, LJ; Harrington, CL; Joshi, AA; Kabbany, MT; Lerman, JB; Lockshin, BN; Mehta, NN; Natarajan, B; Ng, Q; Playford, MP; Prussick, RB; Rivers, JP; Rodante, JA; Sanda, GE; Silverman, JI; Sorokin, AV; Teague, HL | 1 |
| Gormsen, LC; Hjuler, KF; Iversen, L | 1 |
| Ahlman, MA; Egeberg, A; Gelfand, JM; Gislason, GH; Joshi, AA; Lerman, JB; Mallbris, L; Mehta, NN; Rodante, J; Skov, L; Wu, JJ | 1 |
| Pacher, P; Schindler, TH | 1 |
| Ahlman, MA; Chaturvedi, A; Chung, JH; Dey, AK; Gelfand, JM; Harrington, CL; Joshi, AA; Lockshin, BN; Mehta, NN; Natarajan, B; Playford, MP; Powell-Wiley, TM; Rana, A; Rivers, JP; Rodante, JA; Sajja, AP; Teague, HL; Yao, J | 1 |
| Cook, R; Dey, AK; Eder, L; Gladman, DD; Joshi, AA; Mehta, NN; Siegel, EL | 1 |
| Egeberg, A; Gormsen, LC; Hjuler, KF; Iversen, L; Nielsen, J; Vendelbo, MH | 2 |
| Han, J; Kim, BS; Kim, GW; Kim, HS; Kim, MB; Kim, SJ; Ko, HC; Pak, K; Park, MY | 1 |
| Ahlman, MA; Alavi, A; Armstrong, AW; Dey, AK; Duffin, KC; Fuxench, ZC; Gelfand, JM; Harrington, CL; Hubbard, RA; Joshi, AA; Kalb, RE; Mehta, NN; Menter, A; Playford, MP; Rader, DJ; Reilly, MP; Shin, DB; Simpson, EL; Takeshita, J; Torigian, DA; Troxel, AB; Tyring, SK; Van Voorhees, AS; Vanderbeek, SB; Werner, TJ | 1 |
| Aberra, TM; Ahlman, MA; Baumer, Y; Belur, AD; Bluemke, DA; Chen, MY; Chung, J; Dave, J; Dey, AK; Elnabawi, YA; Gelfand, JM; Goyal, A; Groenendyk, JW; Joshi, AA; Lerman, JB; Mehta, NN; Natarajan, B; Playford, MP; Rivers, JP; Rodante, JA; Sajja, AP; Salahuddin, T; Teague, HL | 1 |
| Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N | 1 |
| Aberra, TM; Alavi, A; Baumer, Y; Belur, AD; Bluemke, DA; Chaturvedi, A; Chen, MY; Chung, JH; Dey, AK; Elnabawi, YA; Gelfand, JM; Genovese, LD; Goyal, A; Groenendyk, JW; Harrington, CL; Joshi, AA; Lerman, JB; Mehta, NN; Natarajan, B; Pitman, RK; Playford, MP; Powell-Wiley, TM; Rivers, JP; Rodante, JA; Sanda, GE; Sorokin, AV; Tawakol, A; Teague, HL; Varghese, NJ | 1 |
| Alavi, A; Alvarez, J; Chiesa Fuxench, ZC; Gelfand, JM; Mehta, NN; Noe, MH; Papadopoulos, M; Shin, DB; Takeshita, J; Torigian, DA; Wan, MT; Werner, TJ | 1 |
| Ahlman, MA; Aksentijevich, M; Al Najafi, M; Bluemke, DA; Choi, H; Dey, AK; Elnabawi, YA; Gelfand, JM; Genovese, LD; Goyal, A; Groenendyk, JW; Harrington, CL; Joshi, AA; Kabbany, MT; Mehta, NN; Natarajan, B; Playford, MP; Reddy, AS; Rodante, J; Sadek, A; Shukla, P | 1 |
| Ahlman, MA; Bluemke, DA; Dave, J; Lockshin, BN; Mehta, NN | 1 |
| Kang, SY; Kim, SA; Lee, WW; Park, GY; Youn, SW | 1 |
| Basu, S; Hansson, SH; Hess, S; Høilund-Carlsen, PF; Pedersen, KT | 1 |
| Alavi, A; Bakshi, A; Gelfand, JM; Gholami, S; Takeshita, J | 1 |
| Ahlman, MA; Dave, J; Doveikis, J; Ehrlich, A; Gelfand, JM; Joshi, AA; Kaplan, MJ; Krishnamoorthy, P; Lockshin, BN; Mehta, NN; Naik, HB; Natarajan, B; Ng, Q; Playford, MP; Prussick, RB; Rose, SM; Salahuddin, T; Stansky, E; Teague, H | 1 |
| Rudd, JH; Tarkin, JM | 1 |
| Bruna-Muraille, C; Cuif-Job, A; Guedec-Ghelfi, R; Liehn, JC; Papathanassiou, D; Pochart, JM | 1 |
| Alavi, A; Antigua, J; Baer, A; Foroughi, N; Gelfand, JM; Krishnamoorthy, P; Mehta, NN; Raper, A; Saboury, B; Torigian, DA; Van Voorhees, AS; Yu, Y | 1 |
| Bissonnette, R; Bolduc, C; Guertin, MC; Harel, F; Pressacco, J; Tardif, JC | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Psoriasis
| Article | Year |
|---|---|
FDG-PET/CT in Infectious and Inflammatory Diseases.
Topics: Arthritis, Rheumatoid; Bacterial Infections; Bone Diseases; Endocarditis; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Inflammation; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Vasculitis; Venous Thromboembolism | 2014 |
6 trial(s) available for fluorodeoxyglucose f18 and Psoriasis
| Article | Year |
|---|---|
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.
Topics: Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Psoriasis; Severity of Illness Index; Treatment Outcome | 2022 |
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).
Topics: Adult; Antibodies, Monoclonal, Humanized; Aorta; Arteritis; Biomarkers; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Interleukin-17; Male; Metabolic Syndrome; Middle Aged; Placebos; Positron Emission Tomography Computed Tomography; Psoriasis; Severity of Illness Index; Treatment Outcome | 2020 |
Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and
Topics: Adult; Brain; Depression; Dermatologic Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Psoriasis; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Ustekinumab | 2018 |
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Biomarkers; Blood Glucose; Cholesterol, HDL; Cross-Over Studies; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Insulin Resistance; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Psoriasis; Radiopharmaceuticals; Severity of Illness Index; Time Factors; Treatment Outcome; Ultraviolet Therapy; United States; Vasculitis | 2018 |
Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds | 2018 |
Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Atherosclerosis; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Psoriasis; Radiopharmaceuticals; Single-Blind Method; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
25 other study(ies) available for fluorodeoxyglucose f18 and Psoriasis
| Article | Year |
|---|---|
Heightened splenic and bone marrow uptake of
Topics: Atherosclerosis; Bone Marrow; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Spleen | 2021 |
Abdominal Visceral Adiposity Is Associated with Coronary Artery Plaque Lipid-Rich Necrotic Core Partly Mediated by Bone Marrow Uptake of
Topics: Adiposity; Bone Marrow; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Lipids; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Psoriasis | 2022 |
Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study.
Topics: Anti-Inflammatory Agents; Arthritis, Psoriatic; Biological Factors; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Prospective Studies; Psoriasis | 2023 |
Serum active 1,25(OH)
Topics: Adiposity; Aged; Cardiovascular Diseases; Coronary Angiography; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Immunoassay; Intra-Abdominal Fat; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Risk; Vitamin D | 2019 |
Statin Therapy and Vascular Inflammation Detected by Positron Emission Tomography/Computed Tomography in Patients with Psoriasis.
Topics: Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals | 2021 |
Can positron emission tomography (PET) unravel the link between adipose tissue, vascular inflammation and cardiovascular risk in patients with psoriasis?
Topics: Adipose Tissue; Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2017 |
Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography.
Topics: Adult; Antirheumatic Agents; Aorta; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Phototherapy; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Radiopharmaceuticals; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2017 |
Using FDG-PET/CT to Detect Vascular Inflammation in Patients with Psoriasis: Where to Look? And for What??
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Psoriasis | 2017 |
The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.
Topics: Adult; Aged; Brain Ischemia; Case-Control Studies; Cohort Studies; Denmark; Female; Fluorodeoxyglucose F18; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Positron Emission Tomography Computed Tomography; Psoriasis; Radiopharmaceuticals; Registries; Stroke; Time Factors; United States; Vasculitis | 2017 |
Psoriasis-Related Visceral Adiposity and Arterial Inflammation: A New Adiposity Disease Entity?
Topics: Adiposity; Arteritis; Cohort Studies; Fluorodeoxyglucose F18; Humans; Inflammation; Psoriasis; Risk Factors | 2018 |
Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by
Topics: Adiposity; Adult; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Psoriasis; Radiopharmaceuticals; Risk Factors; Subcutaneous Fat; Time Factors; Vasculitis; Whole Body Imaging | 2018 |
Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.
Topics: Adult; Aged; Antirheumatic Agents; Atherosclerosis; Canada; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with Psoriasis.
Topics: Aged; Aorta; Aortitis; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Panniculitis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Psoriasis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Spleen; Subcutaneous Fat; Whole Body Imaging | 2018 |
Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis.
Topics: Adult; Aorta; Computed Tomography Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis | 2018 |
Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study.
Topics: Adult; Aged; Amygdala; Anti-Inflammatory Agents; Asymptomatic Diseases; Cardiovascular Diseases; Case-Control Studies; Chronic Disease; Computed Tomography Angiography; Coronary Angiography; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Hematopoietic System; Humans; Male; Middle Aged; Multidetector Computed Tomography; Predictive Value of Tests; Prospective Studies; Psoriasis; Radiopharmaceuticals; Risk Factors; Single Photon Emission Computed Tomography Computed Tomography; Stress, Psychological; Treatment Outcome; United States | 2020 |
Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials.
Topics: Adult; Aged; Asymptomatic Diseases; Clinical Trials as Topic; Comorbidity; Cross-Sectional Studies; Ethnicity; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prevalence; Psoriasis; Radiopharmaceuticals; Severity of Illness Index; Smoking; Whole Body Imaging | 2019 |
Association of aortic vascular uptake of
Topics: Adult; Aorta; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis | 2019 |
Vascular inflammation in psoriasis localizes to the arterial wall using a novel imaging technique.
Topics: Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2014 |
Subclinical systemic and vascular inflammation detected by (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with mild psoriasis.
Topics: Adult; Aged; Aorta; Arteritis; Case-Control Studies; Female; Fluorodeoxyglucose F18; Hepatitis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Psoriasis; Radiopharmaceuticals | 2015 |
Assessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images.
Topics: Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals | 2015 |
Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study.
Topics: Adult; Aortitis; Biomarkers; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Immunity, Innate; Inflammation Mediators; Leukocyte Count; Male; Middle Aged; Multimodal Imaging; Neutrophil Activation; Neutrophils; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Psoriasis; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2015 |
Psoriasis: More Than Just Skin Deep.
Topics: Aortitis; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neutrophil Activation; Neutrophils; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis.
Topics: Aged; Aortitis; Body Mass Index; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Panniculitis; Positron Emission Tomography Computed Tomography; Psoriasis; Radiopharmaceuticals; Subcutaneous Fat | 2017 |
Incidental finding of F-18 FDG skin uptake in a patient with psoriasis during the evaluation of a recurrent papillary thyroid carcinoma.
Topics: Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron-Emission Tomography; Psoriasis; Recurrence; Skin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.
Topics: Adult; Aorta; Aortography; Arthrography; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Joints; Liver; Male; Middle Aged; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Skin; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |